| TIME | TOPIC | SPEAKER |
| 08.00-08.30 | Registration | |
| 08.30-08.40 | Pre Test | |
| 08.40-09.00 | Medical Ethics in Daily Practice | Pranawa Martosuwignyo |
| 09.00-09.30 | Management of Hypertensive Crisis with Cardiovascular Emergencies | Siska Suridanda Dany |
| 09.30-10.00 | Hypertensive Crisis in Acute Cerebrovascular Disease: Ischemic Stroke Vs Intracerebral Hemorrhage | Cep Juli |
| 10.00-10.15 | Coffee Break | |
| 10.15-10.45 | Management of Hypertensive Crisis with Renal Dysfunction | Artaria Tjempakasari |
| 10.45-11.15 | Perioperative Hypertension Management | Paskariatne Probodewi |
| 11:30-13:00 | FRIDAY PRAYING & LUNCH | |
| 13.00-14.30 | Interactive case discussion | Estu Rudiktyo |
| TIME | TOPIC | SPEAKER |
| 08.00-08.30 | Registration | |
| 08.30-08.40 | Pre Test | |
| 08.40-09.00 | Medical Ethics in Daily Practice | Pranawa Martosuwignyo |
| 09.00-09.25 | Strict Blood Pressure Control | Erwinanto |
| 09.25-09.50 | Strict Reduction of Sodium Intake | Chia Yook Chin |
| 09.50-10.00 | Q&A | |
| 10.00-10.15 | Coffee Break | |
| 10.15-10.40 | Choice of Preferred Antihypertensive Agents | Pranawa Martosuwignyo |
| 10.40-11.05 | Widespread screening to improve awareness | Yuda Turana |
| 11.05-11.30 | Q&A | |
| 11:30-13:00 | FRIDAY PRAYING & LUNCH | |
| 13.00-13.25 | Home BP-Guided Hypertension Management | Tzung-Dau Wang |
| 13.25-13.50 | Reducing Morning Home BP as the First Target and Night Time BP as the Second Target For High Risk Patients | Kario Kazuomi |
| 13.50-14.15 | Q&A |
| TIME | TOPIC | SPEAKER |
| 08.00-08.30 | Registration | |
| 08.30-08.40 | Pre Test | |
| 08.40-09.00 | Medical Ethics in Daily Practice | Pranawa Martosuwignyo |
| 09.00-09.45 | Out of office BP : the optimum way to diagnose and manage hypertension | Eka Harmeiwaty |
| 09.45-10.00 | Demo and Hands On | |
| 10.00-10.15 | Coffee Break | |
| 10.15-11.00 | Diagnosis and Current Management of Hypertension | Bagus Andi Pramono |
| 11.00-11.30 | Nocturnal hypertension : what we have to know and what we can do | Djoko Wibisono |
| 11:30-13:00 | FRIDAY PRAYING & LUNCH | |
| 13.00-14.30 | Interactive case discussion |
| TIME | TOPIC | SPEAKER |
| 08.00-08.30 | Hypertension update: implications on nursing practice | Irvantri Adijaya, M. Kep., Sp Kep. MB |
| 08.30-09.00 | Role of nursing team in reducing the prevalence of hypertension | Nurlaeci M, Kep |
| 09.00-09.30 | Discussion | |
| 09.30-10.00 | Nursing role to improve patients adherence in hypertension manajemen : Promotion and prevention | Yumi Thesiana , M. Kep |
| 10.00-10.30 | Nursing education for hypertension | Terry Lukita , S. Kep., Ners |
| 10.30-11.00 | Discussion | |
| 11.00-11.30 | Quizz |
| TIME | TOPIC | SPEAKER |
| 07.50 - 08.00 | Ethical Issues in Managing Hypertension | Pukovisa Prawiroharjo |
| 08.00 - 08.30 | What are the Policy Issues with Prevention and Management of Hypertension in Indonesia? | Eva Susanti |
| 08.30 - 09.00 | Possibilities for Expanding Population Screening Using Indonesian MMM Data | Erwinanto |
| TIME | TOPIC |
| 09.00 - 09.30 | Opening Ceremony : Including "In Memory of Our Beloved Dr Nani & Prof Rully" |
| 09.30 - 10.00 | Coffee Break |
| TIME | BALLROOM A | BALLROOM B | BALLROOM C |
| Symposium 1 | Symposium 2 | Symposium 3 | |
| Out of Office Blood Pressure Measurement: The Importance Chair: Iwan Dakota |
Management of Essential Hypertension: The Current Updates Chair: Pranawa Martosoewignyo |
Pharmaceutical Management of Hypertension: What's New? Chair: Parlindungan Siregar |
|
| 10.00 - 10.15 | The advanced devices for blood pressure monitoring Amanda Tiksnadi |
Raising hypertension awareness and medication adherence Adre Mayza |
Current perspective on personalized medicine and hypertension treatment Ismail Setyopranoto |
| 10.15 - 10.30 | Prognostic significance of blood pressure measured in the office, at home and during ambulatory Estu Rudiktyo |
Early Cardiovascular Protection by Initiating Synergistic Single Pill Combination Abdul Wahid |
Current Update of Pharmacological Agents for the Management of Hypertension Zulkhair Ali |
| 10.30 - 10.45 | The Recent Concensus Recommendation on Morning and Nocturnal Hypertension Bryan Williams (ISH) |
The Benefit of Using Selective Beta Blocker for Treating Hypertensive Heart Disease Badai Tiksnadi |
Cardioprotection with Beta-Adrenoceptor Blockers for Heart Failure with Hypertension Rossana Barack |
| 10.45 - 11.00 | Discussion | Discussion | Discussion |
| Lunch Symposium 1 | Lunch Symposium 2 | Lunch Symposium 3 | |
| Dietary management of high blood pressure Chair: Diatri Nari Lastri |
SGLT2i in Cardio Renal Management: Organ Protection Starts Now Chair: Yuda Turana |
Joint with HOPE ASIA Genetic Aspect of hypertension Chair: Jose Roesma |
|
| 11.00 - 11.20 | How much salt is too much for lowering blood pressure and reducing the risk of cardiovascular disease? Based on Most Recent National Data Haerani Rasyid |
SGLT2 Inhibitor in HF Management: One for All, All for One Siti Elkana Nauli |
Epigenetics pathway of salt-sensitive hypertension Ni Made Hustrini |
| 11.20 - 11.40 | How to Implement DASH Diet for Indonesian People? Ida Gunawan |
Contemporary Management of Diabetic Kidney Disease: Update on Recent Clinical Trials Aida Lydia |
Hypertension in Asian Populations: Any difference from the West? Kario Kazuomi |
| 11.40 - 12.00 | Discussion | Discussion | Discussion |
| 12.00 - 13.00 | LUNCH | ||
| Symposium 4 | Symposium 5 | Symposium 6 | |
| The RAAS System and Heart Failure Chair: Wiguno Prodjosudjadi |
Tackling the Current Challenge of Hypertension Management in Daily Practice Chair: Anwar Santoso |
How to Detect the Earliest Sign of Organ Involvement in Hypertension Chair: Freddy Sitorus |
|
| 13.00 - 13.15 | Hypertension and RAAS System Maruhum Bonar Marbun |
Sympathetic Over Drive, Hypertension and Cerebrovascular Risk Eka Harmeiwaty |
The Most Early Signs of Cardiac Involvement by Hypertension BRM Ario Soeryo |
| 13.15 - 13.30 | Disease Progression from Hypertension to Heart Failure Anggia Chairuddin Lubis |
Translating NO Stories Into Clinical Impact in Hypertension Management Ria Bandiara |
Use of Genomic Risk Score for Cardiovascular Disease Risk Prediction Teguh Ranakusuma |
| 13.30 - 13.45 | Single Pil Combination Therapy in Treatment of Hypertension Referred to Updated Guidelines Rahmat Hidayat |
Hypertension Treatment Difference in Age, Gender and Comorbidities: Real World Evidence Giuseppe Mancia |
Heart Rate and Blood Pressure: Connecting the Dots of Hypertension Management Antonia Anna Lukito |
| 13.45 - 14.00 | Discussion | Discussion | Discussion |
| Symposium 7 | Symposium 8 | Symposium 9 | |
| BPV and Clinical Significants Chair: Syafiq Alwi |
BP, Lipid and Cardio Cerebro Vascular Chair: Suhardjono |
New Launch SPC Triple Combination Chair: Arieska Ann Soenarta |
|
| 14.00 - 14.15 | BPV as a Marker and Target for Cardiovascular Outcome Guiseppe Mancia |
When to Start Anti Lipid Therapy in Hypertensive Patients? Ekawatidani Yulianti |
Therapeutic Strategies for Hypertension Based On Recent Guidelines Aryatama |
14.15 - 14.30 | Different Impact of Morning and Nocturnal Hypertension in Kidney Outcome Afiatin |
Hypertension to Reduce Risk of Stroke; Focus on CCB Adrianus Kosasih |
When to start antihypertensive medication with combination therapy? I Made Junior Rina Artha |
| 14.30 - 14.45 | The Role of Telmisartan and Its Combination in Hypertension Management to Minimize Complication Syafrizal Nasution |
How to Prevent Recurrent Episode of Stroke with High Intensity Statin M Kurniawan |
Comprehensive Management of Hypertension from Dual to Triple Combination Rudi Supriyadi |
| 14.45 - 15.00 | Discussion | Discussion | Discussion |
| TIME | TOPIC | SPEAKER |
| 18.30 - 18.45 | Blood Pressure and Hear Failure: How They Impact Each Other in Achieving Heart Failure Treatment Goal | Bryan Williams (ISH) |
| 18.45 - 19.00 | Bridging the Gaps in Chronic Kidney Disease Management | Pranawa Martosuwignyo |
| 19.00- 19.15 | Discussion |
| TIME | TOPIC | SPEAKER |
| 08.00 - 08.30 | Community-based blood pressure screening: where are we now and what can we do? | Saifur Rohman |
| 08.30 - 09.00 | Management of hypertension in low resources setting | Bryan Williams (ISH) |
| 09.00 - 09.30 | INASH AWARD |
| TIME | BALLROOM A | BALLROOM B | BALLROOM C |
| Symposium 10 | Symposium 11 | Symposium 12 | |
| PREVENTION OF HYPERTENSIVE RELATED ORGAN INVOLVEMENT Chair: Frits RW Suling |
CARDIOVASCULAR METABOLIC EFFECT OF SGLT2 INHIBITORS IN HYPERTENSION Chair: Rahmat Hidayat |
Hypertension and Circardian Rhythm Chair: Al Rasyid |
|
| 09.30 - 09.45 | Implementing Single Pill Combination Therapy for Hypertension Tunggul Situmorang |
The Newest Update on SGLT2i in 2023 Em Yunir |
Cerebrovascular Prognosis of Morning Blood Pressure Surge Syahrul Gazali |
| 09.45 - 10.00 | Single Pill Combination Therapy in Patients with Cardiovascular Risk Bambang Budi Siswanto |
Managing the Deadly Duo of HF and CKD Paskariatne Probodewi |
Should Treatment of Hypertension Based on Blood Pressure Level Only? Arieska Ann Soenarta |
| 10.00 - 10.15 | The Relation Between Antihypertension Treatment and Progression of CSVD Salim Harris |
Early Intervention in T2DM in Improving CKD Outcome Pranawa Martosoewignyo |
Benefit of Third Generation of CCB in Hypertension Management Djoko Wibisono |
| 10.15 - 10.30 | Discussion | Discussion | Discussion |
| 10.30 - 11.00 | COFFEE BREAK | ||
| Lunch Symposium 4 | Lunch Symposium 5 | Lunch Symposium 6 | |
| Hypertension Management in COVID-19 Pandemic: Sharing Experiences with Hypertension Management During the COVID-19 Pandemic Chair: Santoso Karo Karo |
Joint with KSH: Geriatric Hypertension Chair: Tunggul D Situmorang |
Obesity and Hypertension Chair: Artaria Tjempakasari |
|
| 11.00 - 11.20 | How to deal with hypertension control post COVID-19 Anwar Santoso |
BPV and the Risk of Dementia Yuda Turana |
Hypertension and Obesity: Should we worry? I Made Putra Swi Antara |
| 11.20 - 11.40 | Hypertension management during the COVID-19 pandemic: what can we learn for the future? Mursyid Bustami |
Late Life Hypertension Kwang - Il Kim (KSH) |
Sleep apnea and Resistant Hypertension Rimawati Tedjasukmana |
| 11.40 - 12.00 | Discussion | Discussion | Discussion |
| 12.00 - 13.00 | LUNCH | ||
| Symposium 13 | Symposium 14 | Symposium 15 | |
| How to Tailor Hypertension Management in Special Condition Chair: Eka Musridharta |
THE BREAKTHROUGH COMBINATION IN MANAGING HYPERTENSION Chair: Nunuk Mardiana |
WOMEN AND HYPERTENSION Chair: Lydia Simatupang |
|
| 13.00 - 13.15 | How to Prescribe Exercise for Hypertension Patients Ade Median |
Global Trends Neuroopthalmology in Diagnosis and Treatment of Hypertenson Ni Nengah Rida Ariarini |
Gender Differences in Blood Pressure Management and Control Anna Ulfah Rahayoe |
| 13.15 - 13.30 | Overview on The Current Hypertension Guidelines: Focus on CCB Chandra Irwanady Mohani |
The deadly line linking sympathetic overactivity and vascular risk Siska Suridanda Danny |
Hypertension Across a Woman's Life Cycle Maria Riastuti |
| 13.30 - 13.45 | The Importance of Blood Pressure Protection: Cause Not All CCB Are Equal Celly Anantaria |
Combining Bisoprolol and Amlodipine: Is It Beneficial? Sari Mumpuni |
Accessibility, Awarenes and affordability for Hypertension in women Sobaryati |
| 13.45 - 14.00 | Discussion | Discussion | Discussion |
| 14.00 - 14.20 | LAUNCHING CONSENSUS | ||
| 14.20 - 14.50 | CLOSING REMARK AND DOOR PRIZE | ||
| TIME | TOPIC | SPEAKER |
| 09.00-09.10 | Introduction | Eka Harmeiwaty, SpS |
| 09.10-09.30 | Safe BP for the heart: How low can we go? | Rarsari Soerarso, SpJP |
| 09.30-09.50 | BP Targets for Renal Preservation | Paramitha Ayu, SpPD |
| 09.50-10.05 | Interactive Case Study | Eka Harmeiwaty, SpS |
| 10.05-10.45 | Discussion | (All) |
| TIME | TOPIC | SPEAKER |
| 09.00-09.10 | Introduction | Prof Parlindungan Siregar, SpPD |
| 09.10-09.30 | Mono or FDC Strategies as a First Step Therapy | Dian Yaniarti, SpJP |
| 09.30-09.50 | Hypertension and Stroke: Neurologist Perspective | Rakhmad Hidayat, SpS |
| 09.50-10.05 | Interactive Case Study | Prof Parlindungan Siregar, SpPD |
| 10.05-10.45 | Discussion | (All) |
| TIME | TOPIC | SPEAKER |
| 09.00-09.10 | Introduction | Ni Made Hustrini, SpPD |
| 09.10-09.30 | Therapies for Chronic Stroke | Ekawatidani Yulianti, SpS |
| 09.30-09.50 | Therapies in Hypertensive Heart Disease | Putra Antara, SpJP |
| 09.50-10.05 | Interactive Case Study | Ni Made Hustrini, SpPD |
| 10.05-10.45 | Discussion | (All) |
| TIME | TOPIC | SPEAKER |
| 09.00-09.10 | Introduction | Adre Mayza, SpS |
| 09.10-09.30 | Role of Valsartan in Treating Hypertension and CV Disease | Prof. Saifur Rohman, SpJP |
| 09.30-09.50 | Rational Combination of ARB for Hypertension | Prof. Suhardjono, SpPD |
| 09.50-10.05 | Interactive Case Study | Adre Mayza, SpS |
| 10.05-10.45 | Discussion | (All) |